Abstract
Hospital use of chlorhexidine (CHX) containing antiseptics to decrease nosocomial infections may promote CHX resistance among pathogenic organisms. Nosocomial bloodstream-infecting Staphylococcus aureus isolates from before and after adoption of hospital-wide CHX bathing were tested for CHX susceptibility, and no decreased susceptibility or resistance-promoting genes were discovered. Infect Control Hosp Epidemiol 2017;38:873-875.
MeSH terms
-
Anti-Infective Agents, Local / pharmacology*
-
Anti-Infective Agents, Local / therapeutic use
-
Bacteremia / microbiology
-
Bacteremia / prevention & control
-
Bacterial Proteins / genetics
-
Baths / methods*
-
Chlorhexidine / pharmacology*
-
Chlorhexidine / therapeutic use
-
Cross Infection / prevention & control
-
Drug Resistance, Bacterial / genetics
-
Hospitals
-
Humans
-
Membrane Transport Proteins / genetics
-
Microbial Sensitivity Tests
-
Staphylococcal Infections / microbiology
-
Staphylococcal Infections / prevention & control
-
Staphylococcus aureus / drug effects*
-
Staphylococcus aureus / genetics
Substances
-
Anti-Infective Agents, Local
-
Bacterial Proteins
-
Membrane Transport Proteins
-
QacB protein, Staphylococcus aureus
-
qacA protein, Staphylococcus aureus
-
Chlorhexidine